IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q3 2024 Holdings

Filed 2024-11-07 | 6 holdings | $51.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tourmaline BIO Inc(TRML)COM89157D105$19.1M741,69137.1%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$17.5M928,96434.0%
Korro BIO Inc(KRRO)COM500946108$12.3M368,08523.9%
Hillevax IncCOM43157M102$983.7K558,9231.9%
Ventyx Biosciences Inc(VTYX)COM92332V107$898.7K412,2251.7%
Kezar Life Sciences IncCOM49372L100$638.1K828,7111.2%